PSMA is highly and specifically expressed on the surface of 90–100% of local prostate tumor cells, and in visceral and bone metastases at all tumor stages [2–5], and its expression increases with tumor aggressiveness [6, 7]. This evidence concerns the gene FOLH1 and neoplasm.